CN1064486A - 嗪并吲哚化合物 - Google Patents

嗪并吲哚化合物 Download PDF

Info

Publication number
CN1064486A
CN1064486A CN92101112A CN92101112A CN1064486A CN 1064486 A CN1064486 A CN 1064486A CN 92101112 A CN92101112 A CN 92101112A CN 92101112 A CN92101112 A CN 92101112A CN 1064486 A CN1064486 A CN 1064486A
Authority
CN
China
Prior art keywords
dihydro
dimethyl
compound
pyridine
oxide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CN92101112A
Other languages
English (en)
Chinese (zh)
Inventor
都築竜二
松本三
松久彰
余田徹
内田渡
柳沢勳
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yamanouchi Pharmaceutical Co Ltd
Original Assignee
Yamanouchi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Pharmaceutical Co Ltd filed Critical Yamanouchi Pharmaceutical Co Ltd
Publication of CN1064486A publication Critical patent/CN1064486A/zh
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
CN92101112A 1991-02-18 1992-02-18 嗪并吲哚化合物 Withdrawn CN1064486A (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP10991891 1991-02-18
JP109918/91 1991-02-18
JP269939/91 1991-07-18
JP26993991 1991-07-18

Publications (1)

Publication Number Publication Date
CN1064486A true CN1064486A (zh) 1992-09-16

Family

ID=26449625

Family Applications (1)

Application Number Title Priority Date Filing Date
CN92101112A Withdrawn CN1064486A (zh) 1991-02-18 1992-02-18 嗪并吲哚化合物

Country Status (11)

Country Link
US (1) US5278158A (enExample)
EP (1) EP0500319A1 (enExample)
KR (1) KR920016450A (enExample)
CN (1) CN1064486A (enExample)
AU (2) AU651171B2 (enExample)
CA (1) CA2061179A1 (enExample)
FI (1) FI920668L (enExample)
IE (1) IE920518A1 (enExample)
NO (1) NO920619L (enExample)
NZ (1) NZ241651A (enExample)
TW (1) TW206230B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9309716D0 (en) * 1993-05-12 1993-06-23 Zeneca Ltd Heterocyclic derivatives
DE69832176T2 (de) * 1997-08-08 2006-08-03 Chugai Seiyaku K.K. Arzneimittel gegen diabetes-komplikationen
US6455554B1 (en) 1999-06-07 2002-09-24 Targacept, Inc. Oxopyridinyl pharmaceutical compositions and methods for use
JPWO2002072049A1 (ja) * 2001-02-27 2004-07-02 山之内製薬株式会社 育毛用医薬組成物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0033612B1 (en) * 1980-02-02 1984-04-11 Beecham Group Plc Pyrano derivatives, a process for their preparation and antihypertensive compositions containing them
ZM7682A1 (en) * 1981-09-25 1983-05-23 Beecham Group Plc Active compounds
GB2107706A (en) * 1981-09-25 1983-05-05 Beecham Group Plc Benzopyrans
FR2578254B1 (fr) * 1985-03-01 1987-03-06 Roussel Uclaf Nouveaux derives de la pyrazolobenzoxazine, leurs sels, procede de preparation, application a titre de medicaments, compositions les renfermant, et des intermediaires
US4902108A (en) * 1986-03-31 1990-02-20 Gentex Corporation Single-compartment, self-erasing, solution-phase electrochromic devices, solutions for use therein, and uses thereof
US4971982A (en) * 1987-07-06 1990-11-20 Hoffmann-La Roche Inc. Benzopyran derivatives
JPH0699439B2 (ja) * 1988-02-03 1994-12-07 日産化学工業株式会社 ピラノベンゾオキサジアゾール誘導体
TW224941B (enExample) * 1989-11-08 1994-06-11 Yamanouchi Pharma Co Ltd

Also Published As

Publication number Publication date
EP0500319A1 (en) 1992-08-26
US5278158A (en) 1994-01-11
AU1101592A (en) 1992-08-20
IE920518A1 (en) 1992-08-26
FI920668A7 (fi) 1992-08-19
AU651171B2 (en) 1994-07-14
NO920619D0 (no) 1992-02-17
CA2061179A1 (en) 1992-08-19
NO920619L (no) 1992-08-19
AU5922994A (en) 1994-05-26
FI920668L (fi) 1992-08-19
KR920016450A (ko) 1992-09-24
NZ241651A (en) 1992-12-23
TW206230B (enExample) 1993-05-21
FI920668A0 (fi) 1992-02-17

Similar Documents

Publication Publication Date Title
CN1028991C (zh) 四氢化萘衍生物的制备方法
CN1310907C (zh) 杂环化合物和以其为有效成分的抗肿瘤药
CN1183132C (zh) 作为5-ht受体配体的四环氮杂�并吲哚化合物
CN1151136C (zh) 缩合哒嗪系化合物
CN1072220C (zh) 作为神经激肽受体拮抗剂的1－苯甲酰基－2－(吲哚基－3－烷基)－哌嗪衍生物
CN1161341C (zh) cGMP磷酸二酯酶的稠合吡啶并哒嗪抑制剂
CN1694704A (zh) （1h－苯并咪唑－2－基）－（哌嗪基）－甲酮衍生物及其相关化合物作为组胺h4受体拮抗剂用于治疗炎性和过敏性疾病
CN1060841A (zh) 喹唑啉衍生物及其制备方法
CN1361779A (zh) 新化合物
CN1102648A (zh) 取代的单-和双-吡啶基甲基吡啶酮类化合物
CN1688583A (zh) 用作治疗醛固酮介导的病症的药物的有机化合物
CN1040981A (zh) 三环化合物
CN1025500C (zh) 杂芳基3-氧-丙腈衍生物的制备方法
CN1023602C (zh) 制备抑制精神的3-哌嗪基苯并唑类衍生物的方法
CN1048242C (zh) 5-氨基-8-甲基-7-吡咯烷喹啉-3-羧酸衍生物及其制造方法和中间体化合物
CN1035255C (zh) 杂三环衍生物
CN1022322C (zh) 稠合吡唑3-氧代-丙腈衍生物的制备方法
CN1083812A (zh) 苯并咪唑类，含有这些化合物的药物组合物和它们的制备
CN1205704A (zh) 2,7－取代的八氢－吡咯并[1,2－a]吡嗪衍生物
CN1071665A (zh) 唑烷酮衍生物
CN1053063A (zh) 喹唑啉衍生物及其制备方法
CN1027536C (zh) 4，5，6，7-四氢化苯并咪唑衍生物制备方法
CN1064486A (zh) 嗪并吲哚化合物
CN1069733A (zh) 6-氧化-氮杂吲哚及其生产方法和中间产品以及药物应用
CN1130183A (zh) 1,4-苯并噁嗪衍生物，含该化合物的药物组合物及其用途

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C01 Deemed withdrawal of patent application (patent law 1993)
WW01 Invention patent application withdrawn after publication